Allied Biotech Corporation (TPEX:1780)

Market Cap	3.23B +92.2%
Revenue (ttm)	880.06M +12.4%
Net Income	107.16M -21.3%
EPS	1.11 -21.4%
Shares Out	96.24M
PE Ratio	30.24
Forward PE	n/a
Dividend	1.25 (3.73%)
Ex-Dividend Date	Jun 4, 2026

Volume	104,591
Open	33.35
Previous Close	33.75
Day's Range	33.20 - 33.65
52-Week Range	16.80 - 36.85
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Allied Biotech

Allied Biotech Corporation engages in the manufacture and sale of carotenoids worldwide. The company’s products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. It also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage ap...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1780

Financial Performance

In 2025, Allied Biotech's revenue was 849.51 million, an increase of 5.28% compared to the previous year's 806.92 million. Earnings were 129.46 million, an increase of 28.25%.